Literature DB >> 21220972

The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas.

Kotaro Yoshio1, Shuhei Sato, Yoshihiro Okumura, Kuniaki Katsui, Mitsuhiro Takemoto, Etsuji Suzuki, Norihisa Katayama, Mitsumasa Kaji, Susumu Kanazawa.   

Abstract

PURPOSE: The aim of this study was to evaluate the local efficacy of I-131 for F-18 fluorodeoxyglucose positron emission tomography (FDG PET)-positive lesions.
METHODS: Whole-body FDG PET/CT was performed on 37 patients (55 cases: 16 men, 21 women; age range: 24-82 years; mean age ± standard deviation: 60.5 ± 16.0 years) with differentiated thyroid cancer after total thyroidectomy. The metastatic or recurrent lesions were divided into 5 categories: primary tumor bed, lymph node, lung, bone, and other. The well-defined lesions were measured on CT, and the sizes were compared before and after radioactive iodine therapy.
RESULTS: The analysis was performed on 37 patients with 44 lesions (lymph node:24, lung:16, bone:4). Sixteen lesions (70%) were increased and 7 (30%) showed no change or reduction when there was positive accumulation on FDG PET/CT and negative accumulation on I-131 (F(+)I(-)) group. In the positive accumulation for both FDG PET/CT and I-131 (F(+)I(+)) group, 5 lesions (63%) were increased and 3 (37%) showed no change or reduction. There was no significant difference for the tendency to increase in size between the F(+)I(-) and the F(+)I(+) groups.
CONCLUSIONS: Lesions which show positive accumulations on FDG PET/CT have a greater tendency to increase in size. FDG-avid lesions are resistant to radioactive iodine therapy with or without I-131 uptake.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220972     DOI: 10.1097/RLU.0b013e318203bb6c

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Interaction of Age at Diagnosis with Transcriptional Profiling in Papillary Thyroid Cancer.

Authors:  Yi-Chiung Hsu; Chien-Liang Liu; Po-Sheng Yang; Chung-Hsin Tsai; Jie-Jen Lee; Shih-Ping Cheng
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

2.  Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer.

Authors:  Byung Hyun Byun; Seong Young Kwon; Ari Chong; Jahae Kim; Su Woong Yoo; Jung-Joon Min; Ho-Chun Song; Henry Hee-Seung Bom
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013

3.  FDG PET Predicts the Effects of 131I and Prognosis for Patients with Bone Metastases from Differentiated Thyroid Carcinoma.

Authors:  Danyang Wang; Yongli Bai; Yanlei Huo; Chao Ma
Journal:  Cancer Manag Res       Date:  2020-12-23       Impact factor: 3.989

Review 4.  Clinical Perspectives of Theranostics.

Authors:  Shozo Okamoto; Tohru Shiga; Nagara Tamaki
Journal:  Molecules       Date:  2021-04-13       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.